Synbora AG

SYNBORA - Digital Therapeutics for Cardiovascular Care

SYNBORA develops a closed-loop, AI-enabled Digital Therapeutics System (Class II, TRL3) for multi-vulnerability cardiovascular care in daily-lie. Combining wearable multimodal sensing with an AI engine and companion apps, it enables continuous, context-aware monitoring and adaptive therapy delivery in real-time. Through a B2B2C SaaS model serving hospitals, rehabilitation clinics, and care organizations, SYNBORA improves post-discharge safety and scales secondary prevention for high-risk CVD patients.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
REGISTER

No news

Milestone

04.02.2026

TRL4-TRL6 Consortium Contracts and Grant Application Completed

Milestone

30.11.2025

TRL3 Peer Reviewed Report Completed

Milestone

14.10.2025

Company Incorporated as SYNBORA AG

Milestone

30.07.2025

Co-founding Team Onboarded (CEO, CTO, CSO, CBO)

Milestone

01.05.2025

DTx Closed Loop - Patent Application Completed

No Jobs

No videos and documents

No Awards

Synbora AG

SYNBORA - Digital Therapeutics for Cardiovascular Care

Website:
synbora.com/

Headquarter:
Bern

Foundation Date:
October 2025

Technology:

  • Biotech

Sectors:

  • Biotech
  • Digital Health
  • Diagnostics
  • Machine Learning / AI
  • Medical devices
  • Patient monitoring